JMM — Past and Present: A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study

Author： Winiarczyk Stanislaw   Gradski Zbigniew   Kosztolich Barbara   Gabler Cornelia   König Gerhardt   Renner Matthias   Saller Robert M.   Prosl Heinrich   Salmons Brian   Günzburg Walter   Hain Johannes  

Publisher： Springer Publishing Company

ISSN： 0946-2716

Source： Journal of Molecular Medicine, Vol.80, Iss.9, 2002-09, pp. : 610-614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

JMM, past and present

By Ganten Detlev  

Journal of Molecular Medicine, Vol. 79, Iss. 1, 2001-03 ,pp. : 4-5

Springer Publishing Company

Access to resources Recommend Favorite

JMM, past and present

By Ganten D.  

Journal of Molecular Medicine, Vol. 79, Iss. 4, 2001-05 ,pp. : 159-160

Springer Publishing Company

Access to resources Recommend Favorite

JMM, past and present

By Ganten Detlev  

Journal of Molecular Medicine, Vol. 78, Iss. 12, 2001-02 ,pp. : 661-662

Springer Publishing Company

Access to resources Recommend Favorite

JMM, past and present

By Ganten Detlev  

Journal of Molecular Medicine, Vol. 79, Iss. 2-3, 2001-04 ,pp. : 74-75

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I–II Study on a Gemcitabine-Cyclophosphamide-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 25-32

Karger

Access to resources Recommend Favorite